Get Started

MSLE

NASD Satellos Bioscience Inc
Nov 3, 2026 · 1:08 PM ET DELAYED Market Open

$6.43 ↑ +0.03 (+0.47%) Trading Up from the previous close of $6.40, $0.09 below the day’s high of $6.52

YTD change
-42.84%
vs 20-day SMA
-6.24%
vs 200-day SMA
N/A

Price ranges

Previous day
$6.40 $6.75
open $6.75 close $6.40
-$0.35 (-5.19%)
Today
$6.39 $6.52
open $6.39 now $6.43
+$0.04 (+0.63%)
Past week
$6.36 $7.19
from $6.54 now $6.43
-$0.11 (-1.68%)
Past month
$6.26 $8.38
from $8.05 now $6.43
-$1.62 (-20.12%)
This year
$5.44 $13.39
from $11.25 now $6.43
-$4.82 (-42.84%)

Price & Performance

-1.96 (-23.44%) / 6M

$5.25$7.02$8.79$10.55May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 52.0% away from all-time highs of $13.39
  • MSLE is down 43% since the beginning of the year
  • MSLE is down 43% over the past 12 months
  • MSLE is down 20% over the past 1 month
  • 1% of all MSLE investors are betting against MSLE

MSLE reads poor: the 12-month move is -43.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.56
Earnings momentum +7.2% Quarterly EPS growth
Quarterly change +7.2%

Valuation

P/E ratio N/A
Enterprise value $73.2M
Beta 1.97

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$61.8M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $136.4M

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenXâ„¢ and Leveraging MyoReGenXâ„¢, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,410.99 -0.46%
JNJ Johnson & Johnson $270.56 -0.97%
ABBV AbbVie, Inc. $288.84 -2.05%
MRK Merck & Co., Inc. $148.36 -0.78%
RHHBY Roche Holding Ltd Sponsored ADR $60.67 -0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.